Avalo Therapeutics Transfers Anti-IL-18 Antibody, AVTX-007 (camoteskimab) to Apollo Therapeutics

Avalo Therapeutics Transfers Anti-IL-18 Antibody, AVTX-007 (camoteskimab) to Apollo Therapeutics - read this article along with other careers information, tips and advice on BioSpace

Related Keywords

Rockville ,Massachusetts ,United States ,Boston ,Cambridge ,Cambridgeshire ,United Kingdom ,London ,City Of ,Ukraine ,Garrya Neil ,Richard Mason ,Christopher Sullivan ,Chris Brinzey ,Kate Burdick ,University College London ,Kings College London ,Avalo Therapeutics Inc ,Apollo Therapeutics Group ,Canale Communications ,Nasdaq ,University Of Cambridge ,Astrazeneca ,Imperial College London ,Apollo Therapeutics Group Limited ,Chief Executive Officer ,Apollo Therapeutics ,Medimmune Limited ,Patient Square Capital ,Rock Springs Capital ,Kings College ,Private Securities Litigation Reform Act ,Avalo Therapeutics ,Rozi Morris ,Resume ,Careers ,Valo Therapeutics Transfers Anti Il 18 Antibody ,Vtx 007 Camoteskimab To Apollo Therapeutics ,Iospace ,Advice ,